1. Home
  2. ITRM vs AQMS Comparison

ITRM vs AQMS Comparison

Compare ITRM & AQMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.31

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Logo Aqua Metals Inc.

AQMS

Aqua Metals Inc.

HOLD

Current Price

$4.84

Market Cap

20.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ITRM
AQMS
Founded
2015
2014
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.3M
20.9M
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ITRM
AQMS
Price
$0.31
$4.84
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$9.00
$12.00
AVG Volume (30 Days)
497.5K
736.3K
Earning Date
03-20-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$390,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$193.01
$550.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.26
$3.37
52 Week High
$1.62
$39.40

Technical Indicators

Market Signals
Indicator
ITRM
AQMS
Relative Strength Index (RSI) 42.44 37.83
Support Level $0.31 $4.72
Resistance Level $0.37 $5.54
Average True Range (ATR) 0.03 0.53
MACD 0.00 -0.05
Stochastic Oscillator 9.44 6.44

Price Performance

Historical Comparison
ITRM
AQMS

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About AQMS Aqua Metals Inc.

Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.

Share on Social Networks: